China
· Delayed Price · Currency is CNY Yunnan Botanee Bio-Technology Group Co.LTD Statistics
Total Valuation
Yunnan Botanee Bio-Technology Group Co.LTD has a market cap or net worth of CNY 20.90 billion. The enterprise value is 18.65 billion.
| Market Cap | 20.90B |
| Enterprise Value | 18.65B |
Important Dates
The last earnings date was Friday, October 25, 2024.
| Earnings Date | Oct 25, 2024 |
| Ex-Dividend Date | Jun 11, 2024 |
Share Statistics
Yunnan Botanee Bio-Technology Group Co.LTD has 420.07 million shares outstanding. The number of shares has decreased by -1.06% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 420.07M |
| Shares Change (YoY) | -1.06% |
| Shares Change (QoQ) | -1.13% |
| Owned by Insiders (%) | 2.62% |
| Owned by Institutions (%) | 8.21% |
| Float | 131.09M |
Valuation Ratios
The trailing PE ratio is 35.35 and the forward PE ratio is 20.46. Yunnan Botanee Bio-Technology Group Co.LTD's PEG ratio is 0.89.
| PE Ratio | 35.35 |
| Forward PE | 20.46 |
| PS Ratio | 3.42 |
| PB Ratio | 3.50 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 178.75 |
| P/OCF Ratio | n/a |
| PEG Ratio | 0.89 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 33.28, with an EV/FCF ratio of 159.53.
| EV / Earnings | 31.49 |
| EV / Sales | 3.05 |
| EV / EBITDA | 33.28 |
| EV / EBIT | 42.99 |
| EV / FCF | 159.53 |
Financial Position
The company has a current ratio of 4.60, with a Debt / Equity ratio of 0.12.
| Current Ratio | 4.60 |
| Quick Ratio | 3.40 |
| Debt / Equity | 0.12 |
| Debt / EBITDA | 1.34 |
| Debt / FCF | 6.43 |
| Interest Coverage | 32.87 |
Financial Efficiency
Return on equity (ROE) is 10.05% and return on invested capital (ROIC) is 4.25%.
| Return on Equity (ROE) | 10.05% |
| Return on Assets (ROA) | 3.69% |
| Return on Capital (ROIC) | 4.25% |
| Revenue Per Employee | 1.59M |
| Profits Per Employee | 153,783 |
| Employee Count | 3,852 |
| Asset Turnover | 0.83 |
| Inventory Turnover | 1.82 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -33.93% in the last 52 weeks. The beta is 0.64, so Yunnan Botanee Bio-Technology Group Co.LTD's price volatility has been lower than the market average.
| Beta (5Y) | 0.64 |
| 52-Week Price Change | -33.93% |
| 50-Day Moving Average | 49.58 |
| 200-Day Moving Average | 53.59 |
| Relative Strength Index (RSI) | 41.99 |
| Average Volume (20 Days) | 8,013,911 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Yunnan Botanee Bio-Technology Group Co.LTD had revenue of CNY 6.11 billion and earned 592.37 million in profits. Earnings per share was 1.41.
| Revenue | 6.11B |
| Gross Profit | 4.40B |
| Operating Income | 433.97M |
| Pretax Income | 703.21M |
| Net Income | 592.37M |
| EBITDA | 493.32M |
| EBIT | 433.97M |
| Earnings Per Share (EPS) | 1.41 |
Balance Sheet
The company has 3.14 billion in cash and 752.05 million in debt, giving a net cash position of 2.39 billion or 5.69 per share.
| Cash & Cash Equivalents | 3.14B |
| Total Debt | 752.05M |
| Net Cash | 2.39B |
| Net Cash Per Share | 5.69 |
| Equity (Book Value) | 6.05B |
| Book Value Per Share | 14.21 |
| Working Capital | 4.36B |
Cash Flow
In the last 12 months, operating cash flow was 492.40 million and capital expenditures -375.47 million, giving a free cash flow of 116.93 million.
| Operating Cash Flow | 492.40M |
| Capital Expenditures | -375.47M |
| Free Cash Flow | 116.93M |
| FCF Per Share | 0.28 |
Margins
Gross margin is 72.04%, with operating and profit margins of 7.10% and 9.70%.
| Gross Margin | 72.04% |
| Operating Margin | 7.10% |
| Pretax Margin | 11.51% |
| Profit Margin | 9.70% |
| EBITDA Margin | 8.08% |
| EBIT Margin | 7.10% |
| FCF Margin | 1.91% |
Dividends & Yields
This stock pays an annual dividend of 0.60, which amounts to a dividend yield of 1.18%.
| Dividend Per Share | 0.60 |
| Dividend Yield | 1.18% |
| Dividend Growth (YoY) | -24.94% |
| Years of Dividend Growth | 3 |
| Payout Ratio | 43.77% |
| Buyback Yield | 1.06% |
| Shareholder Yield | 2.24% |
| Earnings Yield | 2.83% |
| FCF Yield | 0.56% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Yunnan Botanee Bio-Technology Group Co.LTD has an Altman Z-Score of 10.72.
| Altman Z-Score | 10.72 |
| Piotroski F-Score | n/a |